Galapagos NV (GLPG) - Stock price history

Stock price history of Galapagos NV from 2012 to 2025

Annual Stock Price Performance

Year	Performance
2025	16.42%
2024	-33.48%
2023	-8.34%
2022	-19.16%
2021	-44.32%
2020	-53.33%
2019	128.52%
2018	-2.93%
2017	44.20%
2016	5.30%
2015	239.71%
2014	-12.65%
2013	-2.82%
2012	37.35%

Stock price for similar companies or competitors

Company	Stock price	Change 1d%	Country
AstraZeneca AZN	NZ$157.37	0.21%	🇬🇧 UK
Johnson & Johnson JNJ	NZ$356.36	0.46%	🇺🇸 USA
Sanofi SNY	NZ$82.56	-0.31%	🇫🇷 France
AbbVie ABBV	NZ$391.75	0.48%	🇺🇸 USA
Fortress Biotech FBIO	NZ$6.22	2.26%	🇺🇸 USA
Abbott Laboratories ABT	NZ$215.21	-0.20%	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	NZ$53.65	2.83%	🇮🇱 Israel
GlaxoSmithKline GSK	NZ$83.52	-0.04%	🇬🇧 UK
Merck MRK	NZ$180.00	3.59%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Stock price history for Galapagos NV (GLPG)